| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.5 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |